Emirati sovereign wealth fund Mubadala invests in Osstem Implant

Emirati state-owned holding company Mubadala Investment Company has announced an investment in Korean dental implant material manufacturer, Osstem Implant (Osstem), in partnership with MBK Partners and Unison Capital.

Osstem is reportedly the world’s fourth largest dental implant material manufacturer, which focuses on the value segment in more than 30 international markets. The company has manufacturing facilities in Korea and the US, and it provides dental materials, digital equipment, and a full range of auxiliary services in addition to implants.

“With the growing prevalence of dental disorders and demand for cosmetic dentistry across the globe, access to comprehensive dental solutions plays a vital role in improving public health,” said head of life sciences at Mubadala Investment Company, Camilla Macapili Languille. “We are pleased to partner with MBK Partners and Unison Capital to support Osstem in scaling its best-in-class dental solutions in the high-growth value segment to better serve doctors and patients across the globe.”

A consortium formed by MBK Partners and Unison Capital Korea had been acquiring shares of Osstem since March 2023 (Image: Mubadala and Osstem)

Osstem also focuses on helping dentists provide their patients with total dental treatment solutions. The company trains more than 110,000 dentists globally every year through its network of 120 dedicated training centers.

“We are seeing a number of attractive opportunities in the South Korean market and are impressed with the quality of the equity partners and the management team we are backing as part of this transaction. We look forward to supporting the next phase of Osstem’s growth,” said head of Asia, direct investments at Mubadala Investment Company, Luca Molinari.

Although the size of the investment in Osstem was not disclosed, Mubadala Investment Company ranks as one of the UAE’s top sovereign wealth funds, with managed assets totaling US$284.4 billion ranking as high as 13th among global sovereign funds.

Osstem was delisted from the KOSDAQ market on Aug 14 following 16-years on the Korean exchange, after a consortium formed by MBK Partners and Unison Capital Korea (UCK) announced their plans to buy the remaining 3.92% of shares from minority shareholders. The consortium held 96.2% of the company’s shares after two earlier public purchases. The market capitalisation of Osstem was reported at US$2.26 billion (2.93 trillion won) at the time of its final trading period.

Related: Chamlion partners with GPAINNOVA for joint research and development of surface finishing technology